Skip to content

To study the effect of panchbhautika nasal drops in the patients with migraine

An open labelled randomized comparative clinical study to evaluate the efficacy of panchbhautika nasal drops in the management of ardhavabhedaka with special reference to migraine - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/084946
Enrollment
60
Registered
2025-04-16
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G439- Migraine, unspecified

Interventions

None listed

Sponsors

Parul Institute Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients will be enrolled in the study based on the diagnostic criteria for ardhavabhedaka migraine 2. Patients will be selected from 18-60 years Age group 3. Patients who will be fit for Pratimarsh Nasya karma

Exclusion criteria

Exclusion criteria: 1. Patients of ardhavabhedaka migraine who are taking alternative medicines 2. Other known case of any systemic disease HTN COPD etc 3. Patients with conditions such as brain tumors meningitis cervical spondylitis encephalitis referred pain refractive errors or glaucoma will not be enrolled in this study 4. Contraindicated for nasal instillation Pratimarsh Nasya karma

Design outcomes

Primary

MeasureTime frame
To Evaluate the Efficacy of Panchbhautika nasal drops in The Management of Ardhavabhedaka with Special reference to MigraineTimepoint: At baseline on 15th day 30th day 45th day 60th day 75th day and 90th day

Secondary

MeasureTime frame
relief from symptoms of migraineTimepoint: 90 days

Countries

India

Contacts

Public ContactDr Manjiri keskar

Parul Institute of Ayurveda

manjirikeskar@gmail.com9822606358

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026